Answers are grounded in this paper and cite their sources.
Framework identifies genes linked to cancer risk in a genetic context, suggesting broader applications.
Our approach provides a framework for the identification of candidate HRD-related CSGs through combined statistical and clinico-genomics analyses. It is adaptable to other mutational signatures/cancer types and will be most effective when applied to larger and well-annotated datasets.
No takes yet. Share an insight, caveat, or question.
Camacho-Valenzuela et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: